DK1981506T6 - Langtidsbehandling af hiv-infektion med tcm278 - Google Patents

Langtidsbehandling af hiv-infektion med tcm278 Download PDF

Info

Publication number
DK1981506T6
DK1981506T6 DK07712053.3T DK07712053T DK1981506T6 DK 1981506 T6 DK1981506 T6 DK 1981506T6 DK 07712053 T DK07712053 T DK 07712053T DK 1981506 T6 DK1981506 T6 DK 1981506T6
Authority
DK
Denmark
Prior art keywords
tcm278
long term
hiv infection
term treatment
treatment
Prior art date
Application number
DK07712053.3T
Other languages
English (en)
Other versions
DK1981506T3 (da
Inventor
Lieven Elvire Colette Baert
Guenter Kraus
't Klooster Gerben Albert Eleutherius Van
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36446113&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1981506(T6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of DK1981506T3 publication Critical patent/DK1981506T3/da
Application granted granted Critical
Publication of DK1981506T6 publication Critical patent/DK1981506T6/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07712053.3T 2006-01-20 2007-01-19 Langtidsbehandling af hiv-infektion med tcm278 DK1981506T6 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100677 2006-01-20
PCT/EP2007/050516 WO2007082922A2 (en) 2006-01-20 2007-01-19 Long term treatment of hiv- infection with tcm278

Publications (2)

Publication Number Publication Date
DK1981506T3 DK1981506T3 (da) 2013-06-24
DK1981506T6 true DK1981506T6 (da) 2021-06-14

Family

ID=36446113

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07712053.3T DK1981506T6 (da) 2006-01-20 2007-01-19 Langtidsbehandling af hiv-infektion med tcm278

Country Status (28)

Country Link
US (2) US10953009B2 (da)
EP (1) EP1981506B3 (da)
JP (2) JP5754005B2 (da)
KR (2) KR101501475B1 (da)
CN (2) CN103877091A (da)
AP (1) AP2936A (da)
AR (1) AR059097A1 (da)
AU (1) AU2007206901B2 (da)
BR (1) BRPI0707179A2 (da)
CA (1) CA2636436C (da)
CY (1) CY1114089T1 (da)
DK (1) DK1981506T6 (da)
EA (1) EA014914B1 (da)
ES (1) ES2414982T7 (da)
HK (1) HK1125828A1 (da)
HR (1) HRP20130544T4 (da)
IL (1) IL192132A (da)
ME (1) ME01617B (da)
MY (1) MY150717A (da)
NZ (1) NZ569347A (da)
PL (1) PL1981506T6 (da)
PT (1) PT1981506E (da)
RS (1) RS52821B2 (da)
SG (1) SG170073A1 (da)
SI (1) SI1981506T1 (da)
TW (1) TWI458483B (da)
UA (1) UA96436C2 (da)
WO (1) WO2007082922A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
AU2016219555B2 (en) * 2006-06-23 2017-08-10 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
AU2014200819B2 (en) * 2006-06-23 2016-05-26 Janssen Sciences Ireland Uc Aqueous suspensions of TMC278
MX2009000158A (es) * 2006-06-23 2009-01-23 Tibotec Pharm Ltd Suspensiones acuosas de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil ]-amino]-2-pirimidinil]-amino]-benzonitrilo.
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
RU2546529C2 (ru) * 2008-12-24 2015-04-10 Тиботек Фармасьютикалз Имплантируемые устройства для лечения вич
KR101845811B1 (ko) * 2009-09-22 2018-05-18 얀센 알 앤드 디 아일랜드 Ｈｉｖ 감염의 치료 및 예방용 비경구용 제제
US8784858B2 (en) * 2009-12-21 2014-07-22 Janssen R&D Ireland Degradable removable implant for the sustained release of an active compound
US20120295898A1 (en) 2010-01-27 2012-11-22 Mark Richard Underwood Antiviral Therapy
TWI577377B (zh) 2010-09-16 2017-04-11 Ｖｉｉｖ醫療保健公司 醫藥組合物
US9266824B2 (en) 2014-01-13 2016-02-23 Warsaw Orthopedic, Inc. Methods and compositions for making an amino acid triisocyanate
JP6835841B2 (ja) * 2015-11-16 2021-02-24 エボニック オペレーションズ ゲーエムベーハー 非核酸系逆転写酵素阻害剤とポリ（ラクチド−ｃｏ−グリコリド）とを含む注射液
US20190163877A1 (en) * 2017-11-27 2019-05-30 International Business Machines Corporation Decision support for effective long-term drug therapy
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
US6568805B1 (en) * 2001-11-26 2003-05-27 Dan L. Dietz Trust Magnetic buckle for eyeglasses
AU2003210659A1 (en) * 2002-01-24 2003-09-02 Sangstat Medical Corporation Combination therapy for treatment of hiv infection
KR101284361B1 (ko) * 2004-09-02 2013-07-15 얀센 파마슈티카 엔.브이. 4-((4-((4-(2-시아노에텐일)-2,6-디메틸페닐)아미노-2-피리미딘일)아미노)벤조니트릴의 하이드로클로라이드
EA013686B1 (ru) * 2004-09-02 2010-06-30 Янссен Фармацевтика Н.В. Гидрохлорид 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防

Also Published As

Publication number Publication date
EA014914B1 (ru) 2011-02-28
IL192132A (en) 2014-05-28
WO2007082922A8 (en) 2008-01-03
AR059097A1 (es) 2008-03-12
KR20140141699A (ko) 2014-12-10
NZ569347A (en) 2011-07-29
US20210177843A1 (en) 2021-06-17
BRPI0707179A2 (pt) 2011-04-26
CY1114089T1 (el) 2016-07-27
MY150717A (en) 2014-02-28
JP5754005B2 (ja) 2015-07-22
WO2007082922A2 (en) 2007-07-26
KR20080085194A (ko) 2008-09-23
KR101501475B1 (ko) 2015-03-19
HK1125828A1 (en) 2009-08-21
TWI458483B (zh) 2014-11-01
DK1981506T3 (da) 2013-06-24
SI1981506T1 (sl) 2013-08-30
EP1981506A2 (en) 2008-10-22
KR101562943B1 (ko) 2015-10-23
PT1981506E (pt) 2013-06-25
ES2414982T3 (es) 2013-07-23
PL1981506T6 (pl) 2021-07-12
ES2414982T7 (es) 2021-11-05
AP2008004535A0 (en) 2008-08-31
EP1981506B3 (en) 2021-06-09
US20110275654A1 (en) 2011-11-10
IL192132A0 (en) 2009-08-03
JP2013100338A (ja) 2013-05-23
EA200870183A1 (ru) 2009-12-30
RS52821B (en) 2013-10-31
RS52821B2 (sr) 2021-07-30
CA2636436A1 (en) 2007-07-26
US10953009B2 (en) 2021-03-23
JP2009526758A (ja) 2009-07-23
AU2007206901B2 (en) 2013-01-31
PL1981506T3 (pl) 2013-08-30
CN103877091A (zh) 2014-06-25
HRP20130544T1 (en) 2013-07-31
CA2636436C (en) 2014-04-01
TW200806295A (en) 2008-02-01
SG170073A1 (en) 2011-04-29
CN101370504A (zh) 2009-02-18
JP5836983B2 (ja) 2015-12-24
HRP20130544T4 (hr) 2021-08-20
ME01617B (me) 2014-09-20
UA96436C2 (ru) 2011-11-10
EP1981506B1 (en) 2013-03-27
AP2936A (en) 2014-07-31
AU2007206901A1 (en) 2007-07-26
WO2007082922A3 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
DK1981506T6 (da) Langtidsbehandling af hiv-infektion med tcm278
DK1976516T3 (da) Behandling af viral hepatitis
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK2084174T3 (da) Fremstilling af ribofuranosylpyrimidinnukleotider
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
DK3494972T3 (da) Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion
BRPI0820183A2 (pt) Prevenção e tratamento de infecções secundárias após infecção viral
DK2056807T3 (da) Behandling af inflammatoriske sygdomme
DK2211901T3 (da) Vaccination med multiple clader af h5-influenza-a-virus
DK1881848T3 (da) Forebyggelse af hiv-infektion med tmc278
DK2019825T3 (da) Inhibitorer af human immundefektvirus-replikation
DK2700786T3 (da) Modifikation af overførselspassage
DK2097402T3 (da) Makrocykliske inhibitorer af hepatitis c-virus
DK1981859T3 (da) Fremstilling af delmopinol
DK2220076T3 (da) Inhibitorer af replikationen af humant immundefektvirus
DK2125004T3 (da) Synergistisk terapeutisk anvendelse af prothrombinkompleks koncentrater med fviii koncentrater
DK1919904T3 (da) Makrocykliske inhibitorer af hepatitis-c-virus
DK2041270T3 (da) Fremstilling af glycoproteiner
DK2300560T3 (da) Termisk behandling af biomasse
DK1732604T3 (da) Fremgangsmåder til behandling af hiv-infektion
BRPI0811265A2 (pt) Tratamento de sinucleinopatias
DK1776136T3 (da) Behandling af tilstande, der involverer demyelinisering
DK1945277T3 (da) Opretholdelse af desinfektion af medicinsk udstyr
DK2091673T3 (da) Elektromagnetisk behandling af kontaminerede materialer
DK2350116T3 (da) Behandling af biofilm